Company information
- Ticker
- POAS
- Country
- United States
- Sector
- Health Care
- Industry
- Medtech
Phaos Technology (Cayman) Holdings Business Summary
Phaos Technology (Cayman) Holdings Ltd (POAS) is a deep-tech enterprise specializing in advanced optical imaging, generating revenue through the sale of its proprietary OptoNano series of super-resolution microscopes, specialized optical components, and AI-driven imaging software. The company’s business model is built upon its patented Optical Microsphere Nanoscopy (OMN) technology, which enables sub-wavelength imaging beyond the 200nm diffraction limit without the requirement for fluorescent labeling or vacuum conditions. Key business segments include PT-Industrial for semiconductor inspection and material failure analysis, PT-Metrology for high-precision dimensional measurement, and PT-Biology for life science research. Phaos positions itself as a disruptive, cost-effective alternative to established giants such as Carl Zeiss AG, Leica Microsystems (Danaher), Nikon Corporation, and Bruker Corporation, specifically targeting the niche for "label-free" nanoscopy that offers higher resolution than standard optical systems at a fraction of the cost of electron microscopy. The company was founded by a team of prominent academics and industry veterans, led by technical visionary Prof. Hong Minghui, a Fellow of the Academy of Engineering, Singapore, and a former professor at the National University of Singapore (NUS) with expertise in laser precision engineering. As of February 2026, the executive leadership is headed by Gan Hong Loon, who serves as the Interim Chief Executive Officer and Chief Financial Officer following a strategic management transition in late 2025. The board is overseen by Executive Chairman Hook Seng Beh, who brings extensive experience in corporate strategy and governance. This leadership team combines deep academic pedigree with corporate restructuring expertise, focusing on the global commercialization of the firm’s intellectual property in microsphere-assisted imaging for the biotechnology and advanced manufacturing sectors.